What changed
ClinicalTrials.gov, snapshot of 2026-11-15 compared with 2026-11-12: 4 major and 9 minor changes in the tracked trials.
Major changes
Not linked to a program
- NCT05474378 B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme status RECRUITING → ACTIVE_NOT_RECRUITING
- NCT06218914 Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors status RECRUITING → ACTIVE_NOT_RECRUITING
- NCT06745921 Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults status ACTIVE_NOT_RECRUITING → COMPLETED
- NCT06934382 Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma status RECRUITING → ACTIVE_NOT_RECRUITING
Minor changes
2 enrolment, 2 completion slipped, 2 status, 2 new trial, 1 intervention added. Full list: the changes API and MCP tool.
Tracked programs
| Program | Kind | Trials |
|---|---|---|
| anitocabtagene autoleucel AXP000022 | CAR-T cell therapy | 8 |
| axicabtagene ciloleucel AXP000014 | CAR-T cell therapy | 58 |
| brexucabtagene autoleucel AXP000015 | CAR-T cell therapy | 21 |
| ciltacabtagene autoleucel AXP000018 | CAR-T cell therapy | 22 |
| equecabtagene autoleucel AXP000021 | CAR-T cell therapy | 12 |
| idecabtagene vicleucel AXP000017 | CAR-T cell therapy | 19 |
| lisocabtagene maraleucel AXP000016 | CAR-T cell therapy | 36 |
| obecabtagene autoleucel AXP000019 | CAR-T cell therapy | 8 |
| relmacabtagene autoleucel AXP000020 | CAR-T cell therapy | 20 |
| tisagenlecleucel AXP000013 | CAR-T cell therapy | 55 |
| ALVAC(2)-NY-ESO-1(M)/TRICOM AXP000189 | Cancer vaccine | 3 |
| ALVAC-CEA-B7.1 AXP000188 | Cancer vaccine | 1 |
| AVX701 AXP000213 | Cancer vaccine | 2 |
| AVX901 AXP000214 | Cancer vaccine | 2 |
| Ad-MAGEA3 AXP000165 | Cancer vaccine | 3 |
| Ad5-hGCC-PADRE AXP000164 | Cancer vaccine | 1 |
| AdVTMM2-transduced dendritic cell vaccine AXP000166 | Cancer vaccine | 0 |
| CV301 AXP000180 | Cancer vaccine | 7 |
| ETBX-011 AXP000154 | Cancer vaccine | 20 |
| ETBX-021 AXP000155 | Cancer vaccine | 10 |
| ETBX-051 AXP000156 | Cancer vaccine | 20 |
| ETBX-061 AXP000157 | Cancer vaccine | 21 |
| ETBX-071 AXP000158 | Cancer vaccine | 3 |
| GRT-C903 AXP000162 | Cancer vaccine | 2 |
| MVA E2 AXP000191 | Cancer vaccine | 0 |
| MVA-5T4 AXP000184 | Cancer vaccine | 11 |
| MVA-BN-Brachyury-TRICOM AXP000185 | Cancer vaccine | 6 |
| MVA-BN-HER2 AXP000186 | Cancer vaccine | 2 |
| NOUS-209 AXP000163 | Cancer vaccine | 2 |
| PANVAC AXP000179 | Cancer vaccine | 6 |
| PRGN-2009 AXP000160 | Cancer vaccine | 4 |
| TA-HPV AXP000190 | Cancer vaccine | 4 |
| TG4050 AXP000183 | Cancer vaccine | 2 |
| lutadenovec autogene AXP000161 | Cancer vaccine | 3 |
| mesmulogene ancovacivec AXP000181 | Cancer vaccine | 5 |
| p53MVA AXP000187 | Cancer vaccine | 4 |
| rilimogene galvacirepvec/rilimogene glafolivec AXP000178 | Cancer vaccine | 21 |
| tipapkinogene sovacivec AXP000182 | Cancer vaccine | 2 |
| zopapogene imadenovec AXP000159 | Cancer vaccine | 4 |
| ASP9801 AXP000102 | Oncolytic virus | 1 |
| Ad3-hTERT-E1A AXP000072 | Oncolytic virus | 0 |
| Ad5-CD/TKrep AXP000049 | Oncolytic virus | 0 |
| Ad5-D24-GMCSF AXP000066 | Oncolytic virus | 0 |
| Ad5-RGD-D24-GMCSF AXP000068 | Oncolytic virus | 0 |
| Ad5-yCD/mutTK(SR39)rep-ADP AXP000047 | Oncolytic virus | 2 |
| Ad5-yCD/mutTKSR39rep-hIL12 AXP000048 | Oncolytic virus | 2 |
| Ad5/3-Cox2L-D24 AXP000069 | Oncolytic virus | 0 |
| Ad5/3-D24-hNIS AXP000071 | Oncolytic virus | 0 |
| Ad5/3-E2F-d24-GMCSF AXP000067 | Oncolytic virus | 0 |
| Ad5/3-hTERT-E1A-hCD40L AXP000070 | Oncolytic virus | 0 |
| AdAPT-001 AXP000040 | Oncolytic virus | 1 |
| Adze1.C AXP000063 | Oncolytic virus | 1 |
| BI 1831169 AXP000120 | Oncolytic virus | 2 |
| BS-006 AXP000090 | Oncolytic virus | 3 |
| BT-001 AXP000095 | Oncolytic virus | 6 |
| BioTTT001 AXP000046 | Oncolytic virus | 10 |
| C134 AXP000085 | Oncolytic virus | 3 |
| CAN-3110 AXP000087 | Oncolytic virus | 1 |
| CAdVEC AXP000042 | Oncolytic virus | 1 |
| CF33-CD19 AXP000101 | Oncolytic virus | 1 |
| CF33-hNIS AXP000099 | Oncolytic virus | 2 |
| CF33-hNIS-antiPDL1 AXP000100 | Oncolytic virus | 1 |
| CG7060 AXP000054 | Oncolytic virus | 0 |
| CG7870 AXP000053 | Oncolytic virus | 2 |
| CRAd-S-pk7 AXP000052 | Oncolytic virus | 3 |
| G207 AXP000074 | Oncolytic virus | 6 |
| GC001 AXP000108 | Oncolytic virus | 3 |
| GM103 AXP000043 | Oncolytic virus | 1 |
| GO306 AXP000109 | Oncolytic virus | 1 |
| H101 AXP000003 | Oncolytic virus | 21 |
| H103 AXP000064 | Oncolytic virus | 0 |
| HSV1716 AXP000073 | Oncolytic virus | 3 |
| HVJ-E AXP000130 | Oncolytic virus | 2 |
| ICOVIR-5 AXP000050 | Oncolytic virus | 2 |
| ICOVIR-7 AXP000051 | Oncolytic virus | 0 |
| ICVB-1042 AXP000055 | Oncolytic virus | 1 |
| IDOV-Immune AXP000110 | Oncolytic virus | 2 |
| IDOV-SAFE AXP000137 | Oncolytic virus | 3 |
| Ixovex-1 AXP000057 | Oncolytic virus | 1 |
| JNJ-87704916 AXP000092 | Oncolytic virus | 1 |
| JX-929 AXP000097 | Oncolytic virus | 1 |
| KD01 AXP000058 | Oncolytic virus | 2 |
| KH901 AXP000065 | Oncolytic virus | 0 |
| M032 AXP000086 | Oncolytic virus | 3 |
| M1-c6v1 AXP000129 | Oncolytic virus | 2 |
| MEDI5395 AXP000118 | Oncolytic virus | 1 |
| MEM-288 AXP000041 | Oncolytic virus | 1 |
| MG1-MAGEA3 AXP000121 | Oncolytic virus | 3 |
| MTH-68/H AXP000116 | Oncolytic virus | 0 |
| MV-CEA AXP000112 | Oncolytic virus | 2 |
| MV-NIS AXP000113 | Oncolytic virus | 11 |
| MV-s-NAP AXP000114 | Oncolytic virus | 1 |
| MVR-C5252 AXP000081 | Oncolytic virus | 2 |
| NDV-HUJ AXP000117 | Oncolytic virus | 0 |
| NG-350A AXP000038 | Oncolytic virus | 4 |
| NG-641 AXP000039 | Oncolytic virus | 3 |
| NRG-103 AXP000060 | Oncolytic virus | 2 |
| NV1020 AXP000075 | Oncolytic virus | 2 |
| OH2 AXP000089 | Oncolytic virus | 14 |
| ON-01 AXP000138 | Oncolytic virus | 1 |
| ONCOS-102 AXP000035 | Oncolytic virus | 7 |
| ONCR-177 AXP000084 | Oncolytic virus | 1 |
| ORCA-010 AXP000037 | Oncolytic virus | 1 |
| OTS-412 AXP000107 | Oncolytic virus | 3 |
| OVV-01 AXP000132 | Oncolytic virus | 5 |
| OrienX010 AXP000077 | Oncolytic virus | 5 |
| PF-07263689 AXP000105 | Oncolytic virus | 1 |
| PV701 AXP000115 | Oncolytic virus | 2 |
| ParvOryx AXP000127 | Oncolytic virus | 2 |
| R130 AXP000091 | Oncolytic virus | 8 |
| RGV005 AXP000139 | Oncolytic virus | 1 |
| RP3 AXP000079 | Oncolytic virus | 3 |
| Revottack AXP000134 | Oncolytic virus | 1 |
| Rigvir AXP000125 | Oncolytic virus | 0 |
| STI-1386 AXP000135 | Oncolytic virus | 1 |
| SVV-001 AXP000122 | Oncolytic virus | 4 |
| SynOV1.1 AXP000045 | Oncolytic virus | 1 |
| T3011 AXP000080 | Oncolytic virus | 12 |
| TBio-6517 AXP000104 | Oncolytic virus | 1 |
| TG6002 AXP000094 | Oncolytic virus | 4 |
| TG6050 AXP000096 | Oncolytic virus | 1 |
| THEO-260 AXP000056 | Oncolytic virus | 2 |
| TS-2021 AXP000059 | Oncolytic virus | 1 |
| VET3-TGI AXP000106 | Oncolytic virus | 1 |
| VG161 AXP000082 | Oncolytic virus | 9 |
| VG2025 AXP000083 | Oncolytic virus | 6 |
| VRT106 AXP000128 | Oncolytic virus | 9 |
| VSV-02 AXP000133 | Oncolytic virus | 1 |
| VSV-IFNbeta-NIS AXP000119 | Oncolytic virus | 7 |
| VSV-hIFNbeta AXP000136 | Oncolytic virus | 6 |
| VT-101 AXP000061 | Oncolytic virus | 2 |
| VV-GMCSF-Lact AXP000111 | Oncolytic virus | 1 |
| West Nile virus Egypt 101 AXP000131 | Oncolytic virus | 0 |
| YH-02 AXP000062 | Oncolytic virus | 1 |
| YSCH-01 AXP000044 | Oncolytic virus | 5 |
| canerpaturev AXP000076 | Oncolytic virus | 9 |
| cretostimogene grenadenorepvec AXP000006 | Oncolytic virus | 12 |
| delolimogene mupadenorepvec AXP000007 | Oncolytic virus | 4 |
| enadenotucirev AXP000012 | Oncolytic virus | 5 |
| gebasaxturev AXP000123 | Oncolytic virus | 14 |
| hV01 AXP000103 | Oncolytic virus | 3 |
| igrelimogene litadenorepvec AXP000009 | Oncolytic virus | 6 |
| lerapolturev AXP000124 | Oncolytic virus | 12 |
| lontucirev AXP000033 | Oncolytic virus | 1 |
| mumps virus (Asada series) AXP000140 | Oncolytic virus | 0 |
| olvimulogene nanivacirepvec AXP000093 | Oncolytic virus | 10 |
| pelareorep AXP000004 | Oncolytic virus | 35 |
| pexastimogene devacirepvec AXP000011 | Oncolytic virus | 20 |
| rRp450 AXP000088 | Oncolytic virus | 1 |
| sturlimogene erparepvec AXP000078 | Oncolytic virus | 6 |
| suratadenoturev AXP000034 | Oncolytic virus | 8 |
| talimogene laherparepvec AXP000001 | Oncolytic virus | 55 |
| tasadenoturev AXP000005 | Oncolytic virus | 10 |
| teserpaturev AXP000002 | Oncolytic virus | 0 |
| tezemlimogene daxadenorepvec AXP000036 | Oncolytic virus | 2 |
| vocimagene amiretrorepvec AXP000126 | Oncolytic virus | 10 |
| vusolimogene oderparepvec AXP000010 | Oncolytic virus | 8 |
| vvDD-hIL2-RG-1 AXP000098 | Oncolytic virus | 1 |
| zabilugene almadenorepvec AXP000008 | Oncolytic virus | 7 |
| AB-PA01 AXP000223 | Phage therapy | 1 |
| AB-SA01 AXP000222 | Phage therapy | 2 |
| AP-PA02 AXP000220 | Phage therapy | 2 |
| AP-SA02 AXP000221 | Phage therapy | 1 |
| AchromoPhage AXP000240 | Phage therapy | 1 |
| BACTELIDE AXP000238 | Phage therapy | 1 |
| BFC-1 AXP000247 | Phage therapy | 0 |
| BX004 AXP000217 | Phage therapy | 2 |
| BX005 AXP000219 | Phage therapy | 1 |
| BX211 AXP000218 | Phage therapy | 0 |
| DP-QB-MYA-002 AXP000241 | Phage therapy | 1 |
| DP-QB-PSA-005 AXP000242 | Phage therapy | 1 |
| DP-QB-STA-005 AXP000243 | Phage therapy | 1 |
| DUOFAG AXP000234 | Phage therapy | 1 |
| EcoActive AXP000225 | Phage therapy | 1 |
| LBP-EC01 AXP000215 | Phage therapy | 2 |
| MP101 AXP000236 | Phage therapy | 7 |
| Muddy AXP000246 | Phage therapy | 1 |
| NTR-101 AXP000237 | Phage therapy | 1 |
| PGX-0100 AXP000239 | Phage therapy | 1 |
| PP1131 AXP000228 | Phage therapy | 0 |
| PP1493 AXP000229 | Phage therapy | 1 |
| PP1815 AXP000230 | Phage therapy | 1 |
| Pyophage AXP000244 | Phage therapy | 0 |
| SNIPR001 AXP000216 | Phage therapy | 2 |
| ShigActive AXP000226 | Phage therapy | 1 |
| Stafal AXP000231 | Phage therapy | 0 |
| T4 coliphage cocktail (Nestlé) AXP000245 | Phage therapy | 1 |
| TP-102 AXP000224 | Phage therapy | 2 |
| TP-122A AXP000232 | Phage therapy | 1 |
| VRELysin AXP000227 | Phage therapy | 1 |
| WPP-201 AXP000233 | Phage therapy | 1 |
| WRAIR-PAM-CF1 AXP000235 | Phage therapy | 1 |
| MRTX1133 AXP000026 | Targeted small molecule | 1 |
| adagrasib AXP000024 | Targeted small molecule | 39 |
| daraxonrasib AXP000027 | Targeted small molecule | 22 |
| divarasib AXP000025 | Targeted small molecule | 15 |
| elironrasib AXP000028 | Targeted small molecule | 4 |
| fulzerasib AXP000031 | Targeted small molecule | 14 |
| glecirasib AXP000030 | Targeted small molecule | 17 |
| olomorasib AXP000032 | Targeted small molecule | 18 |
| sotorasib AXP000023 | Targeted small molecule | 71 |
| zoldonrasib AXP000029 | Targeted small molecule | 8 |
| ALVAC-HIV (vCP1521) AXP000202 | Vaccine | 4 |
| ALVAC-HIV (vCP2438) AXP000203 | Vaccine | 4 |
| Ad26.COV2.S AXP000168 | Vaccine | 33 |
| Ad26.Mos4.HIV AXP000174 | Vaccine | 8 |
| Ad26.RSV.preF AXP000175 | Vaccine | 15 |
| Ad26.ZEBOV AXP000172 | Vaccine | 25 |
| Ad5-EBOV AXP000173 | Vaccine | 3 |
| Ad5-nCoV AXP000169 | Vaccine | 18 |
| BBV154 AXP000176 | Vaccine | 4 |
| CYD-TDV AXP000206 | Vaccine | 10 |
| ChAdOx1 nCoV-19 AXP000167 | Vaccine | 59 |
| GRAd-COV2 AXP000177 | Vaccine | 2 |
| Gam-COVID-Vac AXP000170 | Vaccine | 20 |
| Imojev AXP000207 | Vaccine | 19 |
| MV-CHIK AXP000208 | Vaccine | 4 |
| MVA-BN-Filo AXP000201 | Vaccine | 22 |
| MVA-BN-RSV AXP000204 | Vaccine | 5 |
| NDV-HXP-S AXP000209 | Vaccine | 6 |
| Sputnik Light AXP000171 | Vaccine | 2 |
| rVSVΔG-ZEBOV-GP AXP000205 | Vaccine | 14 |
| 4D-150 AXP000259 | Viral vector gene therapy | 5 |
| ASN-002 AXP000149 | Viral vector gene therapy | 10 |
| Ad-RTS-hIL-12 AXP000146 | Viral vector gene therapy | 8 |
| E10A AXP000148 | Viral vector gene therapy | 2 |
| Gendicine AXP000141 | Viral vector gene therapy | 4 |
| INGN 241 AXP000153 | Viral vector gene therapy | 1 |
| KB105 AXP000198 | Viral vector gene therapy | 2 |
| KB301 AXP000199 | Viral vector gene therapy | 1 |
| KB407 AXP000194 | Viral vector gene therapy | 2 |
| KB408 AXP000195 | Viral vector gene therapy | 1 |
| KB707 AXP000196 | Viral vector gene therapy | 2 |
| KB801 AXP000197 | Viral vector gene therapy | 1 |
| MQ710 AXP000192 | Viral vector gene therapy | 1 |
| NP2 AXP000200 | Viral vector gene therapy | 3 |
| OCU400 AXP000262 | Viral vector gene therapy | 3 |
| Rexin-G AXP000210 | Viral vector gene therapy | 6 |
| SCH-58500 AXP000152 | Viral vector gene therapy | 3 |
| Strimvelis AXP000211 | Viral vector gene therapy | 5 |
| Zalmoxis AXP000212 | Viral vector gene therapy | 0 |
| aglatimagene besadenovec AXP000144 | Viral vector gene therapy | 13 |
| alferminogene tadenovec AXP000151 | Viral vector gene therapy | 4 |
| alipogene tiparvovec AXP000248 | Viral vector gene therapy | 5 |
| beremagene geperpavec AXP000193 | Viral vector gene therapy | 4 |
| botaretigene sparoparvovec AXP000260 | Viral vector gene therapy | 3 |
| contusugene ladenovec AXP000142 | Viral vector gene therapy | 9 |
| dalnacogene ponparvovec AXP000256 | Viral vector gene therapy | 1 |
| delandistrogene moxeparvovec AXP000254 | Viral vector gene therapy | 11 |
| eladocagene exuparvovec AXP000251 | Viral vector gene therapy | 6 |
| etranacogene dezaparvovec AXP000253 | Viral vector gene therapy | 6 |
| fidanacogene elaparvovec AXP000255 | Viral vector gene therapy | 4 |
| golnerminogene pradenovec AXP000150 | Viral vector gene therapy | 7 |
| ixoberogene soroparvovec AXP000258 | Viral vector gene therapy | 8 |
| laruparetigene zovaparvovec AXP000261 | Viral vector gene therapy | 3 |
| nadofaragene firadenovec AXP000143 | Viral vector gene therapy | 16 |
| ofranergene obadenovec AXP000145 | Viral vector gene therapy | 7 |
| onasemnogene abeparvovec AXP000250 | Viral vector gene therapy | 22 |
| sitimagene ceradenovec AXP000147 | Viral vector gene therapy | 0 |
| surabgene lomparvovec AXP000257 | Viral vector gene therapy | 10 |
| valoctocogene roxaparvovec AXP000252 | Viral vector gene therapy | 7 |
| voretigene neparvovec AXP000249 | Viral vector gene therapy | 6 |